BMKDF
Price
$0.23
Change
-$0.01 (-4.17%)
Updated
Aug 27 closing price
Capitalization
25.45M
LUNG
Price
$1.71
Change
-$0.05 (-2.84%)
Updated
Aug 29, 04:06 PM (EDT)
Capitalization
71.71M
61 days until earnings call
Interact to see
Advertisement

BMKDF vs LUNG

Header iconBMKDF vs LUNG Comparison
Open Charts BMKDF vs LUNGBanner chart's image
Biomark Diagnostics
Price$0.23
Change-$0.01 (-4.17%)
Volume$7.5K
Capitalization25.45M
Pulmonx
Price$1.71
Change-$0.05 (-2.84%)
Volume$100
Capitalization71.71M
BMKDF vs LUNG Comparison Chart in %
Loading...
BMKDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUNG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMKDF vs. LUNG commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMKDF is a Hold and LUNG is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BMKDF: $0.23 vs. LUNG: $1.76)
Brand notoriety: BMKDF and LUNG are both not notable
BMKDF represents the Medical Specialties, while LUNG is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BMKDF: 59% vs. LUNG: 124%
Market capitalization -- BMKDF: $25.45M vs. LUNG: $71.71M
BMKDF [@Medical Specialties] is valued at $25.45M. LUNG’s [@Medical/Nursing Services] market capitalization is $71.71M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMKDF’s FA Score shows that 0 FA rating(s) are green whileLUNG’s FA Score has 1 green FA rating(s).

  • BMKDF’s FA Score: 0 green, 5 red.
  • LUNG’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMKDF and LUNG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMKDF’s TA Score shows that 4 TA indicator(s) are bullish while LUNG’s TA Score has 4 bullish TA indicator(s).

  • BMKDF’s TA Score: 4 bullish, 3 bearish.
  • LUNG’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BMKDF is a better buy in the short-term than LUNG.

Price Growth

BMKDF (@Medical Specialties) experienced а -8.74% price change this week, while LUNG (@Medical/Nursing Services) price change was +15.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.81%. For the same industry, the average monthly price growth was +7.40%, and the average quarterly price growth was +7.26%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.48%. For the same industry, the average monthly price growth was +6.46%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

LUNG is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (-0.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+0.48% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LUNG($71.7M) has a higher market cap than BMKDF($25.4M). BMKDF YTD gains are higher at: 58.530 vs. LUNG (-74.080). BMKDF has higher annual earnings (EBITDA): -1.52M vs. LUNG (-51.84M). LUNG has more cash in the bank: 84.2M vs. BMKDF (88.6K). BMKDF has less debt than LUNG: BMKDF (547K) vs LUNG (56.8M). LUNG has higher revenues than BMKDF: LUNG (90.5M) vs BMKDF (155K).
BMKDFLUNGBMKDF / LUNG
Capitalization25.4M71.7M35%
EBITDA-1.52M-51.84M3%
Gain YTD58.530-74.080-79%
P/E RatioN/AN/A-
Revenue155K90.5M0%
Total Cash88.6K84.2M0%
Total Debt547K56.8M1%
FUNDAMENTALS RATINGS
BMKDF: Fundamental Ratings
BMKDF
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMKDFLUNG
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 24 days ago
71%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BMKDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUNG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPAAY5.690.07
+1.25%
PT Perusahaan Gas Negara Persaro
PAYD2.96N/A
N/A
Paid, Inc.
CETXP0.23N/A
N/A
Cemtrex, Inc.
NASB34.51-0.17
-0.49%
NASB Financial, Inc.
TIAIY5.39-0.39
-6.80%
Telecom Italia S.p.A.

BMKDF and

Correlation & Price change

A.I.dvisor tells us that BMKDF and PAVM have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMKDF and PAVM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMKDF
1D Price
Change %
BMKDF100%
N/A
PAVM - BMKDF
22%
Poorly correlated
-2.90%
IOBCF - BMKDF
20%
Poorly correlated
+4.72%
LUNG - BMKDF
10%
Poorly correlated
-5.38%
ELUT - BMKDF
6%
Poorly correlated
+5.43%
BFLY - BMKDF
3%
Poorly correlated
+3.82%
More

LUNG and

Correlation & Price change

A.I.dvisor indicates that over the last year, LUNG has been loosely correlated with SRTS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if LUNG jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUNG
1D Price
Change %
LUNG100%
-5.38%
SRTS - LUNG
57%
Loosely correlated
+3.77%
BAX - LUNG
53%
Loosely correlated
-0.53%
ALGN - LUNG
52%
Loosely correlated
-0.60%
VAPO - LUNG
42%
Loosely correlated
N/A
KIDS - LUNG
32%
Poorly correlated
-0.88%
More